SUNNYVALE, Calif., April 10, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) announced today that it will report results for its third quarter of fiscal 2014, ended March 31, 2014 on Wednesday, April 30, 2014 after the market closes.
A conference call to review the results will begin at 1:30 p.m. PT/4:30 p.m. ET and will be hosted by Joshua H. Levine, president and chief executive officer, and Gregory Lichtwardt, executive vice president, operations and chief financial officer, both of Accuray.
The conference call dial-in numbers are 1-800-884-5695 (USA) or 1-617-786-2960 (International), Conference ID: 95722306. In addition, a dial-up replay of the conference call will be available beginning April 30, 2014 at 5:30 p.m. PT/8:30 p.m. ET and ending on May 6, 2014. The replay telephone number is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID: 98614914.
A live webcast of the call will also be available from the Investor Relations section of the company's website at http://www.accuray.com/investors. A webcast replay can be accessed on the website beginning Wednesday, April 30, 2014 at approximately 5:30 p.m. PT/8:30 p.m. ET. The replay will remain available until Accuray announces its results for the fourth quarter of fiscal 2014, ending June 30, 2014.
About Accuray
Accuray Incorporated (Nasdaq:ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.
CONTACT: Lynn Pieper
Investor Relations, Westwicke Partners
+1 (415) 202-5678
lynn.pieper@westwicke.com
Media: Madelyn Homick
Manager Communications, Accuray
+1 (408) 789-4335
mhomick@accuray.com
Accuray
